Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

441 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Philadelphia Chromosome as a Clinically Favorable Prognostic Factor of B-cell Acute Lymphoblastic Leukemia/Lymphoblastic Lymphoma in Transplant-Ineligible Elderly Patients in the Era of Molecular-Targeted Therapy.
Saburi M, Nishikawa T, Maehara K, Uraisami K, Takata H, Miyazaki Y, Narahara K, Sasaki H, Abe M, Kohno K, Nakayama T, Ohtsuka E. Saburi M, et al. Among authors: ohtsuka e. Cureus. 2024 Nov 19;16(11):e73988. doi: 10.7759/cureus.73988. eCollection 2024 Nov. Cureus. 2024. PMID: 39703243 Free PMC article.
Clinical significance of NOTCH1 and FBXW7 alterations in adult T-cell leukemia/lymphoma.
Sakamoto Y, Ishida T, Masaki A, Murase T, Ohtsuka E, Takeshita M, Muto R, Choi I, Iwasaki H, Ito A, Kusumoto S, Nakano N, Tokunaga M, Yonekura K, Tashiro Y, Suehiro Y, Iida S, Utsunomiya A, Ueda R, Inagaki H. Sakamoto Y, et al. Among authors: ohtsuka e. Int J Hematol. 2024 Nov 25. doi: 10.1007/s12185-024-03880-3. Online ahead of print. Int J Hematol. 2024. PMID: 39586983
A Higher Neutrophil Count Is Associated with Favorable Achievement of Treatment-Free Remission in Patients with Chronic Myeloid Leukemia Who Received Second Generation Tyrosine Kinase Inhibitor as Frontline Treatment.
Ureshino H, Takeda Y, Kamachi K, Ono T, Iriyama N, Ohtsuka E, Sakaida E, Kimura S. Ureshino H, et al. Among authors: ohtsuka e. Clin Pract. 2024 Jun 21;14(4):1216-1224. doi: 10.3390/clinpract14040097. Clin Pract. 2024. PMID: 39051291 Free PMC article.
Real-world status of treatment for lymphoid neoplasms developed during the course of myeloproliferative neoplasms in Japan.
Edahiro Y, Ochiai T, Hashimoto Y, Ichii M, Okatani T, Omura H, Nakajima K, Sasaki M, Ando J, Takaku T, Koike M, Izumiyama K, Hiraga J, Yano T, Usuki K, Ohtsuka E, Yokoyama K, Oyake T, Takahashi N, Nishida T, Nakao T, Fukuda Y, Akasaka T, Mugitani A, Ando M, Komatsu N. Edahiro Y, et al. Among authors: ohtsuka e. Hematology. 2024 Dec;29(1):2340149. doi: 10.1080/16078454.2024.2340149. Epub 2024 Apr 16. Hematology. 2024. PMID: 38626148 Free article.
441 results